Millennium Pharmaceuticals, Inc. (MLNM) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: michael modeme who wrote (471)	12/10/1999 10:50:00 PM
From: tommysdad	Read Replies (2) of 3044

<<directed evolutionary techniques, pathway modification methods, regulatory techniques, etc. I should have been more specific about what I meant by those terms>> Great terms. But, um, they DON'T GENERATE DRUGS. They generate drug targets. With a good drug target you are about 20% (10%?) of the way there. "There" being defined as a marketable drug. I love companies like MLNM and INCY -- they mean job security for guys (I'm assuming here -- sorry if I'm wrong) like Casaubon and myself. All these new targets are going to require more and more chemistry to find all these new drugs. "Trial and error" and "rational drug design" are going to find 99% of all new drugs for the foreseeable future. The power of MLNM doesn't change that. So, by all means buy a lot of MLNM. But don't ignore the ARQL's and the PCOP's of the world. (OK, ignore PCOP, but you get the picture).

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next